Laxxon Medical
PrivateLast Round
Accelerator
Aug 1, 2023
Total Funding Raised
$12.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Laxxon Medical operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was an Accelerator round in August 2023.
Laxxon Medical is a pharmaceutical technology company that provides an advanced additive manufacturing platform for precise and programmable oral drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laxxon Medical Comparables
Compare Laxxon Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triastek | 87% | |
| Aprecia Pharmaceuticals | 80% | |
| Craft Health | 78% |
For institutional investors. Book with your work email.
Laxxon Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 1, 2023 | ||||
| VC Round | Mar 7, 2022 | ||||
| Series A | Nov 1, 2021 | ||||
| Seed | Oct 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laxxon Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| German Accelerator | Accelerator |
| Evonik Venture Capital | VC Round |
| bm|t beteiligungsmanagement thüringen | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Grew 21% QoQ from 24 to 29 employees.
- Sep 12, 2026
Monthly visitors grew 35% MoM, from 4.8K to 6.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 21, 2026
Laxxon Medical is to participate in the Jefferies Global Healthcare Conference by holding one-on-one investor meetings in the United Kingdom from Nov 16th-19th '26.
For institutional investors. Book with your work email.
Laxxon Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laxxon Medical's valuation, stock price, and market status.
Is Laxxon Medical a public or private company?
Laxxon Medical is a private company.
What is the current stock price of Laxxon Medical?
Laxxon Medical is a private company, so its shares have no public market price. Caplight tracks Laxxon Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laxxon Medical worth (valuation)?
Valuation information for Laxxon Medical is not publicly available.
Can I buy Laxxon Medical stock?
Laxxon Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laxxon Medical's last funding round?
Laxxon Medical's most recent funding round was Accelerator on August 1, 2023.
Who are the main investors in Laxxon Medical?
Key investors in Laxxon Medical include Evonik Venture Capital, bm|t beteiligungsmanagement thüringen.
Will Laxxon Medical IPO soon?
No public IPO plans have been announced for Laxxon Medical.
How can I track Laxxon Medical secondary market activity?
Caplight tracks bids, offers, and trades in Laxxon Medical's shares on secondary markets.